Ping Wang

机构：Tianjin Medical University Cancer Institute and Hospital, University Medical Center, Maastricht University, Zhengzhou University, ERN GUARD-Heart, Shaoxing People's Hospital · ORCID：0000-0002-8876-4210

发表论文 111 篇 · 总被引 4307 次 · h-index 31

代表论文

• Implications of Genetic Testing in Dilated Cardiomyopathy (2020 · Circulation Genomic and Precision Medicine · 被引 127)
• Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences (2020 · European Heart Journal · 被引 126)
• Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF (2021 · JACC Heart Failure · 被引 91)
• Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study (2022 · BMC Geriatrics · 被引 70)
• The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy (2021 · European Journal of Heart Failure · 被引 63)
• A Global Longitudinal Strain Cut-Off Value to Predict Adverse Outcomes in Individuals with a Normal Ejection Fraction (2021 · ESC Heart Failure · 被引 36)